Unity Biotechnology, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.62 | $157.41 M | -2.5 | 51 | $0 |
 AVIR
|
Atea Pharmaceuticals, Inc. | $3.32 | $311.63 M | -1.9 | 75 | $0 |
 BEAM
|
Beam Therapeutics Inc. | $26.32 | $1.91 B | -14.51 | 472 | $377.71 M |
 BXRX
|
Baudax Bio, Inc. | $0.19 | $950,330 | -0 | 9 | $1.27 M |
 CNTB
|
Connect Biopharma Holdings Limited | $0.99 | $108.00 M | -1.81 | 81 | $0 |
 DRMA
|
Dermata Therapeutics, Inc. | $1.19 | $1.47 M | -0.25 | 8 | $0 |
 EDIT
|
Editas Medicine, Inc. | $2.78 | $435.86 M | -2.56 | 265 | $78.12 M |
 ENSC
|
Ensysce Biosciences, Inc. | $0.64 | $4.14 M | -0.17 | 7 | $2.23 M |
 EXAI
|
Exscientia plc | $5.31 | $679.46 M | -4.05 | 483 | $19.75 M |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 HOOK
|
HOOKIPA Pharma Inc. | $3.12 | $79.07 M | -1.71 | 151 | $20.13 M |
 HRTX
|
Heron Therapeutics, Inc. | $1.24 | $542.35 M | -6.55 | 126 | $127.04 M |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 NTLA
|
Intellia Therapeutics, Inc. | $15.12 | $2.19 B | -4.23 | 526 | $36.28 M |
 NUVB
|
Nuvation Bio Inc. | $2.88 | $684.66 M | -8.66 | 203 | $0 |
 NXTC
|
NextCure, Inc. | $1.34 | $38.88 M | -0.61 | 82 | $0 |
 OVID
|
Ovid Therapeutics Inc. | $1.15 | $210.00 M | -4.11 | 25 | $391,695 |
 PBLA
|
Panbela Therapeutics, Inc. | $0.30 | $1.80 M | 0.01 | 7 | $0 |
 PRME
|
Prime Medicine, Inc. | $3.59 | $788.60 M | -3.01 | 234 | $0 |
 RNA
|
Avidity Biosciences, Inc. | $49.99 | $2.54 B | -8.99 | 253 | $9.56 M |
 RXRX
|
Recursion Pharmaceuticals, Inc. | $6.92 | $1.96 B | -5.22 | 500 | $44.58 M |
 VERV
|
Verve Therapeutics, Inc. | $5.40 | $409.24 M | -1.82 | 255 | $11.76 M |
 WINT
|
Windtree Therapeutics, Inc. | $0.49 | $1.88 M | 0.24 | 20 | $0 |